NEPHROS, INC. Debt Instrument, Fee Amount
NEPHROS, INC. (NEPH) had Debt Instrument, Fee Amount of $120.00 thousand as of 2014-06-30, per its 10-Q filed 2014-08-14.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFeeAmount · last filed 2015-04-15
- 2014-06-30: Debt Instrument, Fee Amount $120.00K.
- 2014-03-31: Debt Instrument, Fee Amount $120.00K.
- 2013-05-31: Debt Instrument, Fee Amount $104.00K.
- 2013-05-22: Debt Instrument, Fee Amount $104.00K.
| Period end | Debt Instrument, Fee Amount |
|---|---|
| 2014-06-30 | $120.00K 10-Q · filed 2014-08-14 |
| 2014-03-31 | $120.00K 10-Q · filed 2014-05-14 |
| 2013-05-31 | $104.00K 10-K · filed 2014-03-28 |
| 2013-05-22 | $104.00K 10-K · filed 2015-04-15 |
| 2013-03-31 | $104.00K 10-Q · filed 2013-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |